Evaluation of in vitro mutagenicity and genotoxicity of magnetite nanoparticles
Loading...
Date
2013
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Drug Discoveries & Therapeutics
Series Info
Drug Discoveries & Therapeutics;7
Doi
Scientific Journal Rankings
Abstract
For successful application of nanomaterials
in bioscience, it is essential to understand the
biological fate and potential toxicity of nanoparticles.
The aim of this study is to evaluate the genetic safety
of magnetite nanoparticles (MNPs) (Fe3O4) in order
to provide their diverse applications in life sciences,
such as drug development, protein detection, and gene
delivery. Concentrations of 10 ppm, 30 ppm, and 70 ppm
(10-70 μg/mL) of the MNPs of 8.0 ± 2.0 nm were used.
Characterization of MNPs was done with transmission
electron microscopy (TEM), X-Ray Diffractometry
(XRD) and a vibrating sample magnetometer (VSM).
The MNPs mutagenic potential was evaluated using the
Salmonella Ames test with Salmonella strains TA100,
TA2638, TA102, and TA98 in the presence and the
absence of metabolic activation with S9-liver extract.
Genetic mutations at the chromosomal level and extent
of DNA damage using the alkaline Comet assay were
applied to peripheral blood lymphocytes and HEK-293
cell lines respectively. There were significant changes in
the results of the Salmonella mutagenicity test at the 70
ppm concentration of MNPs which might reflect their
mutagenic activity at higher concentrations. Cytogenetic
evaluation revealed the absence of genetic mutations
at the chromosomal level. The extent of DNA damage
quantified by Comet assay and the mutagenicity study
using Ames test were significantly correlated for the
MNPs. Our results indicated that magnetite nanoparticles
with the defined physicochemical properties caused
apparent toxicity at higher concentrations of 30 ppm and
70 ppm without chromosomal abnormalities under the
experimental conditions of this study.
Description
Keywords
Magnetite nanoparticles, mutagenicity, genotoxicity
Citation
1. Hongwei G, Pak LH, Kenneth WT, Ling W, Bing X. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other grampositive bacteria at ultralow concentration. J Am Chem Soc. 2003; 125:15702-15703. 2. Salah TA, Baker MM, Kamel HM, Abdel Kader MH. Magnetite nanoparticles as a single dose treatment for iron deficience anemia. 2010; PCT, WO 2010/034319 A1. 3. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F. Genotoxicity investigation on nanomaterials: Methods, preparations and characterization of test material, potential artifacts and limitations-Many questions, some answers. Mutat Res. 2009; 681:241-258. 4. Schwertmann U, Cornell RM. Iron oxides in the laboratory: Preparation and characterization, General preparative Techniques (Chapter 2). Weinheim; Chichester: Wiley-VCH, 2000; pp. 19-25. 5. Sun J, Zhou S, Hou P, Yang Y, Weng J, Li X, Li M. Synthesis and characterization of biocompatible Fe3O4 nanoparticles. J Biomed Mater Res A. 2007; 80:333-341. 6. Guo L, Von Dem Bussche A, Buechner M, Yan A, Kane AB, Hurt RH. Adsorption of essential micronutrients by carbon nanotubes and implications for nano-toxicity testing, Small. 2008; 4:721-727. 7. Xuan S, Hao L, Jiang W, Gong X, Hu Y, Chen Z. Preparation of water-soluble magnetite nanocrystals through hydrothermal approach. J Magn Magn Mater. 2007; 308:210-213. 8. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175:184-191. 9. Maron DM, Ames BN. Revised method for the Salmonella mutagenicity assay. Mutat Res. 1983; 113:173-215. 10. Anderson D, Plewa MJ. The international Comet assay workshop. Mutagenesis. 1998; 13:67-73. 11. Henderson L, Wolfreys A, Fedyk J, Bourner C, Wndebank S. The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis. 1998; 13:89-94. 12. Savage JRK. Annotation: Classification and relationships of induced chromosomal structural changes. J Med Genet. 1976; 13:103-122. 13. Wang J, Chen Q, Zeng C, Hou B. Magnetic-fieldinduced growth of single crystalline Fe3O4 nanowires. Adv Mater. 2004; 16:137-140. 14. Giannotti E, Vandin L, Repeto P, Comelli R. A comparison of the in vitro Comet with the in vitro chromosome aberration assay using whole human blood or Chinese hamster lung cells: Validation study using range of novel pharmaceuticals. Mutagenesis. 2002; 17:163-170. 15. O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem. 1993; 268:8298-8303. 16. Kamada NM, Shakurai M, Miyamoto K, Sanada I, Sadamori N, Fukuhara S, Sabe S. Chromosome abnormalities in adult T-cell Leukemia/lymphoma: A karyotype review committee report. Cancer Res. 1992; 52:1481-1493. 17. Kane RS, Stroock AD. Nanobiotechnology: Protein nonmaterial interaction. Biotechnol progr. 2007; 23:316- 319. 18. Martín M, Terradas M, Iliakis G, Tusell L, Genescà A. Breaks invisible to the DNA damage response machinery accumulate in ATM-deficient cells. Genes Chromosomes Cancer. 2009; 48:745-759. 19. Pan Y, Neuss S, Leifert A, Fischer M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. Size dependent cytotoxicity of gold nanoparticles. Small. 2007; 3:1941-1949. 20. Rehn B, Seiler S, Rehn S, Bruch J, Maierd M. Investigations on the inflammatory and genotoxic lung effect of two types of titanium dioxide: Untreated and surface treated. Toxicol Appl Pharmacol. 2003; 189:84-95. 21. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrim H, GruneT. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol. Med. 2004; 36:976-984. 22. Edmond K, Baarine M, Pelloux S, Marc Riedinger J, Froulin F, Tourneur Y, Lizard G. Iron nanoparticles increase 7-ketocholesterol-induced cell death, inflammation, and oxidation on murine cardiac HL1-NB cells. Int J Nanomedicine. 2010; 5:185-195. 23. Giri AK, Banerjee S. Genetic toxicology of four commonly used benzodiazepines: A review. Mutat Res. 1996; 340:93-108.